153 related articles for article (PubMed ID: 37878724)
21. Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.
Ma S; Zhang J; Guo Q; Cao C; Bao K; Liu L; Chen CD; Liu Z; Yang J; Yang N; Yao Z; Shi L
Cancer Lett; 2022 Apr; 530():29-44. PubMed ID: 35051531
[TBL] [Abstract][Full Text] [Related]
22. DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors.
Folly-Kossi H; Graves JD; Garan LAW; Lin FT; Lin WC
Cancer Res Commun; 2023 Oct; 3(10):2096-2112. PubMed ID: 37756561
[TBL] [Abstract][Full Text] [Related]
23. The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription.
Sjøttem E; Rekdal C; Svineng G; Johnsen SS; Klenow H; Uglehus RD; Johansen T
Nucleic Acids Res; 2007; 35(19):6648-62. PubMed ID: 17913746
[TBL] [Abstract][Full Text] [Related]
24. Delineation of a minimal topoisomerase II binding protein 1 for regulated activation of ATR at DNA double-strand breaks.
Ruis K; Huynh O; Montales K; Barr NA; Michael WM
J Biol Chem; 2022 Jul; 298(7):101992. PubMed ID: 35490781
[TBL] [Abstract][Full Text] [Related]
25. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival.
Yamane K; Wu X; Chen J
Mol Cell Biol; 2002 Jan; 22(2):555-66. PubMed ID: 11756551
[TBL] [Abstract][Full Text] [Related]
26. TOPBP1 takes RADical command in recombinational DNA repair.
Liu Y; Smolka MB
J Cell Biol; 2016 Feb; 212(3):263-6. PubMed ID: 26811424
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the interaction between the human DNA topoisomerase IIbeta-binding protein 1 (TopBP1) and the cell division cycle 45 (Cdc45) protein.
Schmidt U; Wollmann Y; Franke C; Grosse F; Saluz HP; Hänel F
Biochem J; 2008 Jan; 409(1):169-77. PubMed ID: 17887956
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
29. S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde.
Wong VC; Cash HL; Morse JL; Lu S; Zhitkovich A
Cell Cycle; 2012 Jul; 11(13):2526-37. PubMed ID: 22722496
[TBL] [Abstract][Full Text] [Related]
30. CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication.
Feng H; Lu J; Song X; Thongkum A; Zhang F; Lou L; Reizes O; Almasan A; Gong Z
Nucleic Acids Res; 2020 Nov; 48(19):10940-10952. PubMed ID: 33010150
[TBL] [Abstract][Full Text] [Related]
31. Cell Cycle-Dependent Switch of TopBP1 Functions by Cdk2 and Akt.
Liu K; Graves JD; Lee YJ; Lin FT; Lin WC
Mol Cell Biol; 2020 Mar; 40(8):. PubMed ID: 31964753
[TBL] [Abstract][Full Text] [Related]
32. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
Laine A; Nagelli SG; Farrington C; Butt U; Cvrljevic AN; Vainonen JP; Feringa FM; Grönroos TJ; Gautam P; Khan S; Sihto H; Qiao X; Pavic K; Connolly DC; Kronqvist P; Elo LL; Maurer J; Wennerberg K; Medema RH; Joensuu H; Peuhu E; de Visser K; Narla G; Westermarck J
Cancer Res; 2021 Aug; 81(16):4319-4331. PubMed ID: 34145035
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
Liu K; Graves JD; Lin FT; Lin WC
J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
[TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
[TBL] [Abstract][Full Text] [Related]
35. Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Xiao G; Lundine D; Annor GK; Canar J; Ellison V; Polotskaia A; Donabedian PL; Reiner T; Khramtsova GF; Olopade OI; Mazo A; Bargonetti J
Cancer Res; 2020 Feb; 80(3):394-405. PubMed ID: 31776133
[TBL] [Abstract][Full Text] [Related]
36. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
[TBL] [Abstract][Full Text] [Related]
37. BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.
Karakashev S; Zhu H; Yokoyama Y; Zhao B; Fatkhutdinov N; Kossenkov AV; Wilson AJ; Simpkins F; Speicher D; Khabele D; Bitler BG; Zhang R
Cell Rep; 2017 Dec; 21(12):3398-3405. PubMed ID: 29262321
[TBL] [Abstract][Full Text] [Related]
38. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
[TBL] [Abstract][Full Text] [Related]
39. TopBP1: A BRCT-scaffold protein functioning in multiple cellular pathways.
Wardlaw CP; Carr AM; Oliver AW
DNA Repair (Amst); 2014 Oct; 22():165-74. PubMed ID: 25087188
[TBL] [Abstract][Full Text] [Related]
40. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
